1-3 of 3
May-Lill Garly, MD PhD
Close
Sort by
Journal Articles

Nonacog Beta Pegol for Prophylactic Treatment of Children with Hemophilia B: Up to 3.5-Year Data from the Paradigm™5 Clinical Trial

Susan Kearney, MD, Elena Santagostino, Manuel Carcao, MD, Faraizah Abdul Karim, MD, Masashi Taki, MD PhD, Meng Yao Lu, MD, May-Lill Garly, MD PhD, Marek Zak, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1092.
https://doi.org/10.1182/blood.V130.Suppl_1.1092.1092
Published: 2017
Journal Articles

Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial

Manuel Carcao, Carmen Altisent, PhD, Giancarlo Castaman, Katsuyuki Fukutake, MD PhD, Aida Inbal, MD, Bryce A. Kerlin, Craig M. Kessler, MD, Riitta Lassila, MD PhD, Johannes Oldenburg, Prof, Anders Rosholm, May-Lill Garly, MD PhD, Diane J. Nugent, MD
Journal: Blood
Blood (2016) 128 (22): 2573.
https://doi.org/10.1182/blood.V128.22.2573.2573
Published: 2016
Journal Articles

New Data on the Safety and Efficacy of Recombinant FXIII in Patients with Congenital FXIII A-Subunit Deficiency

Katsuyuki Fukutake, MD PhD, Manual Carcao, MD, Aida Inbal, MD, Bryce A. Kerlin, MD, Johannes Oldenburg, MD PhD, Anders Rosholm, MSc, PhD, May-Lill Garly, MD PhD, Diane J. Nugent, MD
Journal: Blood
Blood (2014) 124 (21): 1520.
https://doi.org/10.1182/blood.V124.21.1520.1520
Published: 2014